about
Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainWhole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response.Clusters versus affinity-based approaches in F. tularensis whole genome search of CTL epitopes.Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne DiseasesDevelopment of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC genes results in attenuation for growth in human macrophages and in vivo virulence in mice and reveals a unique phenotype for pdpC.Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines.The use of resazurin as a novel antimicrobial agent against Francisella tularensis.Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes.TolC-dependent modulation of host cell death by the Francisella tularensis live vaccine strain.Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis.Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.
P2860
Q30275022-C5C872A1-28A4-4B1F-B896-06FB6345827AQ30411506-580392A6-081E-42B1-8209-C08B0F4482A6Q33916280-E3BCCF33-096B-44DF-8519-D63051D11C8EQ34260154-C70EFFC2-9591-4A54-BCBE-8D2190884CCEQ35598662-E473CBD0-3284-4844-B8C1-0CA7D32D6030Q35670540-227B7120-1768-4CC9-853A-87A6027952D2Q36646703-99446378-CEE5-46F6-B9AF-346DEAF63A0CQ36650280-F596E480-96C5-4534-BF9D-8710FFA145AAQ37370030-CB9D7E85-3E82-4486-99F1-67BAF41D03FEQ37439350-3ED1E785-AD3A-4DF5-B80A-1E01D712610DQ37713313-062786E4-A96B-40CF-91D7-368CF3D9ED70Q40093204-7F8664F1-8DA3-4DA3-A304-F74A1FCB3D32Q47368891-EB530B66-109C-42AD-9B5C-58DF62DD41B6Q50133614-1BF4D8EF-1EAC-4B52-9F4C-9876D69E02B0Q55001017-3E957C1C-F640-494A-BA02-FAE188420A15Q55259221-D218F302-A5A0-478C-8AF8-0C9871281CED
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vaccines against tularemia.
@ast
Vaccines against tularemia.
@en
type
label
Vaccines against tularemia.
@ast
Vaccines against tularemia.
@en
prefLabel
Vaccines against tularemia.
@ast
Vaccines against tularemia.
@en
P2093
P2860
P356
P1433
P1476
Vaccines against tularemia.
@en
P2093
Araceli E Santiago
Eileen M Barry
Leah E Cole
P2860
P304
P356
10.4161/HV.10297
P577
2009-12-11T00:00:00Z